Perspectives on the treatment of malignant pleural mesothelioma

SM Janes, D Alrifai, DA Fennell - New England Journal of …, 2021 - Mass Medical Soc
Mesothelioma Most mesotheliomas originate in the pleura and are due to asbestos
exposure. The incidence is decreasing somewhat with asbestos remediation, but mortality …

Mesothelioma: Scientific clues for prevention, diagnosis, and therapy

M Carbone, PS Adusumilli… - CA: a cancer journal …, 2019 - Wiley Online Library
Mesothelioma affects mostly older individuals who have been occupationally exposed to
asbestos. The global mesothelioma incidence and mortality rates are unknown, because …

Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non …

A Scherpereel, J Mazieres, L Greillier… - The Lancet …, 2019 - thelancet.com
Background There is no recommended therapy for malignant pleural mesothelioma that has
progressed after first-line pemetrexed and platinum-based chemotherapy. Disease control …

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆

S Popat, P Baas, C Faivre-Finn, N Girard… - Annals of …, 2022 - annalsofoncology.org
Incidence of malignant pleural mesothelioma (MPM) is generally higher in males than
females and is attributed to historical differences in exposures with world-standardised …

ERS/EACTS statement on the management of malignant pleural effusions

AC Bibby, P Dorn, I Psallidas, JM Porcel… - European journal of …, 2019 - academic.oup.com
Malignant pleural effusions (MPE) are a common pathology, treated by respiratory
physicians and thoracic surgeons alike. In recent years, several well-designed randomized …

Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology clinical practice guideline

HL Kindler, N Ismaila, SG Armato III… - Journal of Clinical …, 2018 - ascopubs.org
Purpose To provide evidence-based recommendations to practicing physicians and others
on the management of malignant pleural mesothelioma. Methods ASCO convened an …

[HTML][HTML] British Thoracic Society Guideline for the investigation and management of malignant pleural mesothelioma

I Woolhouse, L Bishop, L Darlison, D De Fonseka… - Thorax, 2018 - thorax.bmj.com
Refer all patients with a chest X-ray suggestive of MPM urgently (via the 2-week wait
suspected cancer pathway in England and Wales). Consider referral for further investigation …

Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial

BCJ Cho, L Donahoe, PA Bradbury, N Leighl… - The Lancet …, 2021 - thelancet.com
Background A novel approach for managing malignant pleural mesothelioma, surgery for
mesothelioma after radiotherapy (SMART), consisting of a short accelerated course of high …

Malignant pleural mesothelioma: recent developments

K Sinn, B Mosleh, MA Hoda - Current opinion in oncology, 2021 - journals.lww.com
Malignant pleural mesothelioma: recent developments : Current Opinion in Oncology Malignant
pleural mesothelioma: recent developments : Current Opinion in Oncology Log in or Register …

ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma

I Opitz, A Scherpereel, T Berghmans… - European journal of …, 2020 - academic.oup.com
Abstract The European Respiratory Society (ERS)/European Society of Thoracic Surgeons
(ESTS)/European Association for Cardio-Thoracic Surgery (EACTS)/European Society for …